Related Experiment Video
Updated: Oct 9, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Changes of Serum Ficolin-3 and C5b-9 in Patients with Heart Failure
Hongli Li1, Fangfang Zhang2, Dan Zhang3
1Hongli Li, Department of Cardiology, Baoding First Central Hospital, Baoding, Hebei 071000, China.
Insights
Serum ficolin-3 levels decrease with worsening heart failure, while C5b-9 levels increase. These markers, ficolin-3 and C5b-9, do not correlate with the cause of heart failure.
Area of Science:
- Cardiology
- Immunology
- Biochemistry
Background:
- Heart failure (HF) is a complex clinical syndrome with significant morbidity and mortality.
- Biomarkers are crucial for assessing cardiac function and disease severity in HF patients.
- Ficolin-3 and the terminal complement complex C5b-9 are implicated in inflammatory processes.
Purpose of the Study:
- To investigate the correlation between serum ficolin-3 and C5b-9 levels and cardiac function, as indicated by NT-proBNP, in heart failure patients.
- To assess the relationship of these markers with the severity of heart failure.
- To determine if ficolin-3 and C5b-9 levels are associated with the etiology of heart failure.
Main Methods:
- Sixty heart failure patients (NYHA class II-IV) were enrolled and compared to 20 healthy controls.
- Serum levels of ficolin-3, C5b-9, and NT-proBNP were measured.
- Correlation analyses were performed between these markers and heart failure severity and etiology.
Main Results:
- Serum concentrations of ficolin-3 and C5b-9 were significantly different between heart failure patients and controls.
- Ficolin-3 showed a negative correlation with NT-proBNP (r=-0.606, p<0.0001), indicating inverse association with heart failure severity.
- C5b-9 demonstrated a positive correlation with NT-proBNP (r=0.499, p<0.0001), suggesting direct association with heart failure severity.
Conclusions:
- Serum ficolin-3 is inversely associated with heart failure severity.
- Serum C5b-9 is positively associated with the severity of cardiac impairment in heart failure.
- Neither ficolin-3 nor C5b-9 levels showed a significant association with the underlying etiology of heart failure.
Objectives:
To investigate the correlation of serum ficolin-3 and C5b-9 with cardiac function and NT-proBNP in patients with heart failure.
Methods:
Sixty patients with heart failure admitted to the Baoding First Central Hospital from May 2019 to May 2020 were selected and divided into three groups according to the classification of New York Heart Association (NYHA). Patients with NYHA grade II, III, and IV were included into group A, B, and C, respectively. Among the population undergoing physical examination at the same time, 20 cases with no significant difference in age and gender from the experimental group were selected as the control group (Group-N), and their clinical data were recorded. The serum levels of ficolin-3, C5b-9 and NT-proBNP in each group were detected and compared.
Results:
The serum concentrations of ficolin-3 and C5b-9 in Group N were significantly different from those in Group A, B and C (p<0.05), the difference between Group C and Group A and B was statistically significant (p<0.05), there was no significant difference between group A and B (p>0.05). The correlation analysis between serum ficolin-3 and NT-proBNP showed that serum ficolin-3 was negatively correlated with NT-proBNP (r=-0.606, p<0.0001), while the correlation analysis between serum C5b-9 and NT-proBNP showed that serum C5b-9 was positively correlated with NT-proBNP (r=0.499, p<0.0001). According to the etiology of heart failure, patients with heart failure were divided into coronary heart disease (25 cases), dilated cardiomyopathy (15 cases) and others (20 cases). The differences of ficolin-3 and C5b-9 among patients were compared, and there was no statistical difference (p<0.05).
Conclusion:
Ficolin-3 was inversely associated with the severity of heart failure, while C5b-9 was positively associated with the severity of cardiac impairment. Both of them have nothing to do with the etiology of heart failure.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
Related Concept Videos
Heart Failure III: Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Pathophysiology of Heart Failure